Request for Measures and Domains To Use in Development of a Standardized Instrument for Use in Public Reporting of Family Experience of Pediatric Inpatient Care, 81945-81947 [2011-33290]
Download as PDF
<![CDATA[
81945
Federal Register / Vol. 76, No. 250 / Thursday, December 29, 2011 / Notices
Exhibit 2 shows the estimated
annualized cost burden associated with
respondents’ time to participate in this
research. The total cost burden is
estimated to be $37,363 annually.
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Activity
Number of
responses per
respondent
Hours per
response
Total burden
hours
MEPS Cancer SAQ .........................................................................................
3,500
1
30/60
1750
Total ..........................................................................................................
3,500
n/a
n/a
1750
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents
Activity
Total burden
hours
Average
hourly wage
rate*
Total cost
burden hours
MEPS Cancer SAQ .........................................................................................
3,500
1,750
$21.35
$37,363
Total ..........................................................................................................
3,500
1,750
n/a
37,363
* Based on the mean average hourly rate for all occupations (00–0000), National Compensation Survey: Occupational Wages in the United
States May 2010, ‘‘U.S. Department of labor, Bureau of Labor Statistics’’.
Estimated Annual Costs to the Federal
Government
Exhibit 3 shows the estimated total
cost for the Cancer SAQ. Since the SAQ
will only be used once in 2012 the total
and annual costs are identical. The total
cost is approximately $1,050,000.
EXHIBIT 3—ESTIMATED TOTAL AND ANNUALIZED COST
Cost component
Total cost
Annualized
cost
Sampling Activities ...................................................................................................................................................
Interviewer Recruitment and Training .....................................................................................................................
Data Collection Activities .........................................................................................................................................
Data Processing ......................................................................................................................................................
Production of Public Use Data Files .......................................................................................................................
Project Management ................................................................................................................................................
$20,000
0
300,000
600,000
80,000
50,000
$20,000
0
300,000
600,000
80,000
50,000
Total ..................................................................................................................................................................
1,050,000
1,050,000
wreier-aviles on DSK3TPTVN1PROD with NOTICES
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ healthcare
research and healthcare information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
VerDate Mar<15>2010
15:12 Dec 28, 2011
Jkt 226001
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Dated: December 21, 2011.
Carolyn M. Clancy,
Director.
Request for Measures and Domains To
Use in Development of a Standardized
Instrument for Use in Public Reporting
of Family Experience of Pediatric
Inpatient Care
[FR Doc. 2011–33293 Filed 12–28–11; 8:45 am]
AGENCY:
BILLING CODE 4160–90–M
PO 00000
Agency for Healthcare Research
and Quality (AHRQ), HHS.
Notice of request for measures
and domains.
ACTION:
Section 401(a) of the
Children’s Health Insurance Program
Reauthorization Act of 2009 (CHIPRA),
Public Law 111–3, amended the Social
Security Act (the Act) to enact section
1139A (42 U.S.C. 1320b–9a). Section
1139A(b) charged the Department of
SUMMARY:
Frm 00037
Fmt 4703
Sfmt 4703
E:\FR\FM\29DEN1.SGM
29DEN1
wreier-aviles on DSK3TPTVN1PROD with NOTICES
81946
Federal Register / Vol. 76, No. 250 / Thursday, December 29, 2011 / Notices
Health and Human Services with
improving pediatric health care quality
measures. The Agency for Healthcare
Research and Quality (AHRQ) is
soliciting the submission of instruments
or domains (for example, key concepts)
measuring aspects of families’
experience with the quality of inpatient
medical and surgical hospital care from
all researchers, vendors, hospitals,
stakeholders, and other interested
parties. The survey development team
of Children’s Hospital Boston Center of
Excellence for Pediatric Quality
Measurement (CEPQM), is one of the
CHIPRA Pediatric Quality Measures
Program (PQMP) Centers of Excellence,
which were created pursuant to an
interagency agreement between the
Centers for Medicare & Medicaid
Services (CMS) and AHRQ, and are
funded through cooperative agreement
awards with AHRQ. AHRQ is interested
in instruments and items through which
families of pediatric patients assess the
care their child receives during the
child’s inpatient stay. The goal is to
develop a standardized instrument for
use in the public reporting of family
experience of pediatric inpatient care.
The team developing this survey
intends to submit it to the CAHPS
Consortium to request use of the CAHPS
trademark. The survey will be
developed in accordance with CAHPS
Survey Design Principles and will
develop implementation instructions
based on those for CAHPS instruments
(https://www.cahps.AHRQ.gov/AboutCAHPS/Principles.aspx.) All CAHPS
surveys are available to users free of
charge and are published on the AHRQ
Web site.
DATES: Please submit materials January
30, 2012. AHRQ will not respond to
individual submissions, but will
consider all suggestions.
ADDRESSES: Electronic submissions are
encouraged, preferably as an email with
an electronic file in a standard word
processing format as an email
attachment. Submissions may also be in
the form of a letter to: Maushami
DeSoto, MHA, Ph.D., Staff Service
Fellow, Office of Extramural Research,
Education and Priority, Populations
Agency for Healthcare Research and
Quality, 540 Gaither Rd, Rockville, MD
20850, Phone: (301) 427–1546, Fax:
(301) 427–1238, Email:
Maushami.DesotoAHRQ.hhs.gov.
All submissions must include a
written statement from the submitter
that it will grant AHRQ the necessary
rights to use, modify, and adapt the
submitted instruments, items, and their
documentation for the development of
this survey and its dissemination for
VerDate Mar<15>2010
15:12 Dec 28, 2011
Jkt 226001
AHRQ purposes. In accordance with
CHIPRA’s charge to improve pediatric
quality care measures, and consistent
with AHRQ’s mandate to disseminate
research results, 42 U.S.C. 299c–3,
AHRQ purposes include public
disclosure and dissemination (e.g., on
the AHRQ Web site) of AHRQ products
and the results of AHRQ-sponsored
research and activities. The written
statement must be signed by an
individual authorized to act for any
holder of copyright and/or data rights
on each submitted measure or
instrument. The authority of the
signatory to provide such authorization
should be described in the letter.
Submitters must attach a proposed
license granting all of the abovereferenced rights, including the
following terms:
• A worldwide, royalty-free,
nonexclusive, irrevocable license to
AHRQ and those acting on its behalf to
reproduce, prepare derivative works of,
and otherwise use the submitted
materials for the development of AHRQ
products, including a standardized
instrument for use in the public
reporting of family experience of
pediatric inpatient care; and
• The right of AHRQ and those acting
on its behalf to publicly disseminate, in
any media (including AHRQ’s Web site),
any derivative works that AHRQ or
those acting on its behalf develops
based on the submitted materials.
Submission Guidelines
When submitting instruments, please
include, to the extent that it is available:
• Name of the instrument;
• Copies of the full instrument, in all
languages available;
• Domains or key concepts included
in the instrument;
• Instrument reliability (internal
consistency, test-retest, etc) and validity
(content, construct, criterion-related);
• Results of cognitive testing;
• Results of field-testing;
• Current use of the instrument (who
is using it, what it is being used for, how
instrument findings are reported, and by
whom the findings are used); and
• Relevant peer-reviewed journal
articles or full citations.
When submitting domains, please
include, to the extent available:
• Detailed descriptions of question
domain and specific purpose;
• Sample questions, in all languages
available; and
• Relevant peer-reviewed journal
articles or full citations. For all
submissions, please also include:
• A brief cover letter summarizing the
information requested above for
submitted instruments and domains,
respectively;
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
• Complete information about the
person submitting the material,
including:
(a) Name;
(b) Title;
(c) Organization;
(d) Mailing address;
(e) Telephone number;
(f) Email address; and
(g) The written statement granting
AHRQ the necessary rights to use,
modify, and adapt the submitted
instruments, items, and their supporting
documentation for the development of
the survey and its dissemination for
AHRQ purposes, as described above.
FOR FURTHER INFORMATION CONTACT:
Maushami DeSoto, MHA, Ph.D.
SUPPPLEMENTARY INFORMATION: Section
401(a) of the Children’s Health
Insurance Program Reauthorization Act
of 2009 (CHIPRA), Public Law 111–3,
amended the Social Security Act (the
Act) to enact section 1139A (42 U.S.C.
1320b–9a). Since the law was passed,
the Agency for Healthcare Research and
Quality (AHRQ) and the Centers for
Medicare & Medicaid Services (CMS)
have been working together to
implement selected provisions of the
legislation related to children’s health
care quality. Section 1139A(b) of the Act
charged the Department of Health and
Human Services with improving
pediatric health care quality measures.
To implement the law, AHRQ and CMS
have established the CHIPRA Pediatric
Quality Measures Program (PQMP),
which is designed to enhance select
pediatric quality measures and develop
new measures as needed.
The Children’s Hospital Boston
Center of Excellence for Pediatric
Quality Measurement (CEPQM) is one of
seven CHIPRA PQMP Centers of
Excellence, which were created
pursuant to an interagency agreement
between CMS and AHRQ and funded
through cooperative agreement awards
with AHRQ. CEPQM has been assigned
to develop a family experience of
pediatric inpatient care measure to be
considered as a standardized instrument
for publicly reporting pediatric
inpatient hospital family experiences
voluntarily by State Medicaid and CHIP
programs and to be used by providers,
consumers, other public and private
purchasers, and others. The team
developing this survey intends to
submit it to the CAHPS Consortium to
request use of the CAHPS trademark.
Existing instruments or domains
submitted should capture the family’s
experience of hospital or related care
(for example, preparation for discharge
or care coordination). The survey
development team is looking for items
E:\FR\FM\29DEN1.SGM
29DEN1
Federal Register / Vol. 76, No. 250 / Thursday, December 29, 2011 / Notices
for which families of pediatric
inpatients are generally the best or only
judge; for example, the family can best
say if the provider spent sufficient time
with them or explained things in ways
they could understand. Existing
instruments that have been tested
should have a high degree of reliability
and validity; and evidence of wide use
will be helpful.
Dated: December 20, 2011.
Carolyn M. Clancy,
AHRQ Director.
[FR Doc. 2011–33290 Filed 12–28–11; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
World Trade Center Health Program
Scientific/Technical Advisory
Committee (WTCHP STAC or Advisory
Committee), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463) the Centers for Disease
Control and Prevention (CDC),
announces the following meetings of the
aforementioned committee:
COMMITTEE PUBLIC MEETING TIMES AND
DATES: (All times are Eastern Standard
Time).
1 p.m.–5
p.m., January 24, 2012.
This meeting is available via the USA
toll-free, dial-in number: 1–(888) 801–
1939. To be automatically connected to
the meeting, you will need to enter the
following participant code: 62062756.
PUBLIC COMMENT TIMES AND DATE:
4 p.m.–4:45 p.m., January 24, 2012.
Please note that the public comment
period ends at the time indicated or
following the last call for comments,
whichever is earlier. Members of the
public who want to comment must sign
up by providing their name by mail,
facsimile, email, or telephone, as given
below. Each commenter will be
provided up to five minutes for
comment. A limited number of time
slots are available and will be assigned
on a first come-first served basis.
Written comments will also be accepted
from those unable to attend the public
session.
Status: Open to the public, limited
only by the number of telephone lines.
The conference line will accommodate
up to 100 callers; therefore it is
suggested that those interested in calling
wreier-aviles on DSK3TPTVN1PROD with NOTICES
TELECONFERENCE MEETING:
VerDate Mar<15>2010
15:12 Dec 28, 2011
Jkt 226001
in to listen to the committee meeting
share a line when possible.
Background: The Advisory Committee
was established by Public Law 111–347
(The James Zadroga 9/11 Health and
Compensation Act of 2010, Title XXXIII
of the Public Health Service Act),
enacted on January 2, 2011 and codified
at 42 U.S.C. 300mm–300mm–61.
Purpose: The purpose of the Advisory
Committee is to review scientific and
medical evidence and to make
recommendations to the World Trade
Center (WTC) Program Administrator
regarding additional WTC Health
Program eligibility criteria and potential
additions to the list of covered WTCrelated health conditions. Title XXXIII
of the Public Health Service Act
established within the Department of
Health and Human Services (HHS), the
World Trade Center (WTC) Health
Program, to be administered by the WTC
Program Administrator. The WTC
Health Program provides: (1) Medical
monitoring and treatment benefits to
eligible emergency responders and
recovery and cleanup workers
(including those who are Federal
employees) who responded to the
September 11, 2011, terrorist attacks,
and (2) initial health evaluation,
monitoring, and treatment benefits to
residents and other building occupants
and area workers in New York City who
were directly impacted and adversely
affected by such attacks (‘‘survivors’’).
Certain specific activities of the WTC
Program Administrator are reserved to
the Secretary, HHS, to delegate at her
discretion; other WTC Program
Administrator duties not explicitly
reserved to the Secretary, HHS, are
assigned to the Director, NIOSH. The
administration of the Advisory
Committee established under Section
300mm–1(a) is left to the Director of
NIOSH in his role as WTC Program
Administrator. CDC and NIOSH provide
funding, staffing, and administrative
support services for the Advisory
Committee. The charter was issued on
May 12, 2011, and will expire on May
12, 2013.
MATTERS TO BE DISCUSSED: The agenda
for the Advisory Committee meeting
includes: WTC Health Program Research
Priorities and the petition to add cancer
to the list of WTC Health Program
covered conditions. The agenda is
subject to change as priorities dictate. In
the event an individual cannot attend,
written comments may be submitted.
The comments should be limited to two
pages and submitted to the contact
person below by January 18, 2012.
Efforts will be made to provide the twopage written comments received by the
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
81947
deadline below to the committee
members before the meeting. Comments
in excess of two pages will be made
publicly available at the NIOSH docket
(https://www.cdc.gov/niosh/docket/
archive/docket248.html).
PUBLIC COMMENT SIGN-UP AND
SUBMISSIONS TO THE DOCKET: To sign up
to provide public comments or to
submit comments to the docket, send
information to the NIOSH Docket Office
by one of the following means:
Mail: NIOSH Docket Office, Robert A.
Taft Laboratories, MS–C–34, 4676
Columbia Parkway, Cincinnati, Ohio
45226.
Facsimile: (513) 533–8285.
Email: nioshdocket@cdc.gov.
Telephone: (513) 533–8611.
Submissions to the docket should
reference docket #248.
Policy on Redaction of Committee
Meeting Transcripts (Public Comment):
Transcripts will be prepared and posted
to NIOSH Docket 248 within 60 days
after the meeting. If a person making a
comment gives his or her name, no
attempt will be made to redact that
name. NIOSH will take reasonable steps
to ensure that individuals making
public comments are aware of the fact
that their comments (including their
name, if provided) will appear in a
transcript of the meeting posted on a
public Web site. Such reasonable steps
include: (a) A statement read at the start
of the meeting stating that transcripts
will be posted and names of speakers
will not be redacted; and (b) A printed
copy of the statement mentioned in (a)
above will be displayed on the table
where individuals sign up to make
public comments. If individuals in
making a statement reveal personal
information (e.g., medical information)
about themselves, that information will
not usually be redacted. The CDC
Freedom of Information Act coordinator
will, however, review such revelations
in accordance with the Freedom of
Information Act and if deemed
appropriate, will redact such
information. Disclosures of information
concerning third party medical
information will be redacted.
CONTACT PERSON FOR MORE INFORMATION:
Paul J. Middendorf, Ph.D., Designated
Federal Official, NIOSH, CDC, 4676
Columbia Parkway, MailStop R–45,
Cincinnati, Ohio 45226, Telephone: 1
(888) 982–4748; email: wtcstac@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the
E:\FR\FM\29DEN1.SGM
29DEN1
]]>Agencies
[Federal Register Volume 76, Number 250 (Thursday, December 29, 2011)]
[Notices]
[Pages 81945-81947]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-33290]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Request for Measures and Domains To Use in Development of a
Standardized Instrument for Use in Public Reporting of Family
Experience of Pediatric Inpatient Care
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of request for measures and domains.
-----------------------------------------------------------------------
SUMMARY: Section 401(a) of the Children's Health Insurance Program
Reauthorization Act of 2009 (CHIPRA), Public Law 111-3, amended the
Social Security Act (the Act) to enact section 1139A (42 U.S.C. 1320b-
9a). Section 1139A(b) charged the Department of
[[Page 81946]]
Health and Human Services with improving pediatric health care quality
measures. The Agency for Healthcare Research and Quality (AHRQ) is
soliciting the submission of instruments or domains (for example, key
concepts) measuring aspects of families' experience with the quality of
inpatient medical and surgical hospital care from all researchers,
vendors, hospitals, stakeholders, and other interested parties. The
survey development team of Children's Hospital Boston Center of
Excellence for Pediatric Quality Measurement (CEPQM), is one of the
CHIPRA Pediatric Quality Measures Program (PQMP) Centers of Excellence,
which were created pursuant to an interagency agreement between the
Centers for Medicare & Medicaid Services (CMS) and AHRQ, and are funded
through cooperative agreement awards with AHRQ. AHRQ is interested in
instruments and items through which families of pediatric patients
assess the care their child receives during the child's inpatient stay.
The goal is to develop a standardized instrument for use in the public
reporting of family experience of pediatric inpatient care. The team
developing this survey intends to submit it to the CAHPS Consortium to
request use of the CAHPS trademark. The survey will be developed in
accordance with CAHPS Survey Design Principles and will develop
implementation instructions based on those for CAHPS instruments
(https://www.cahps.AHRQ.gov/About-CAHPS/Principles.aspx.) All CAHPS
surveys are available to users free of charge and are published on the
AHRQ Web site.
DATES: Please submit materials January 30, 2012. AHRQ will not respond
to individual submissions, but will consider all suggestions.
ADDRESSES: Electronic submissions are encouraged, preferably as an
email with an electronic file in a standard word processing format as
an email attachment. Submissions may also be in the form of a letter
to: Maushami DeSoto, MHA, Ph.D., Staff Service Fellow, Office of
Extramural Research, Education and Priority, Populations Agency for
Healthcare Research and Quality, 540 Gaither Rd, Rockville, MD 20850,
Phone: (301) 427-1546, Fax: (301) 427-1238, Email:
Maushami.DesotoAHRQ.hhs.gov.
All submissions must include a written statement from the submitter
that it will grant AHRQ the necessary rights to use, modify, and adapt
the submitted instruments, items, and their documentation for the
development of this survey and its dissemination for AHRQ purposes. In
accordance with CHIPRA's charge to improve pediatric quality care
measures, and consistent with AHRQ's mandate to disseminate research
results, 42 U.S.C. 299c-3, AHRQ purposes include public disclosure and
dissemination (e.g., on the AHRQ Web site) of AHRQ products and the
results of AHRQ-sponsored research and activities. The written
statement must be signed by an individual authorized to act for any
holder of copyright and/or data rights on each submitted measure or
instrument. The authority of the signatory to provide such
authorization should be described in the letter. Submitters must attach
a proposed license granting all of the above-referenced rights,
including the following terms:
A worldwide, royalty-free, nonexclusive, irrevocable
license to AHRQ and those acting on its behalf to reproduce, prepare
derivative works of, and otherwise use the submitted materials for the
development of AHRQ products, including a standardized instrument for
use in the public reporting of family experience of pediatric inpatient
care; and
The right of AHRQ and those acting on its behalf to
publicly disseminate, in any media (including AHRQ's Web site), any
derivative works that AHRQ or those acting on its behalf develops based
on the submitted materials.
Submission Guidelines
When submitting instruments, please include, to the extent that it
is available:
Name of the instrument;
Copies of the full instrument, in all languages available;
Domains or key concepts included in the instrument;
Instrument reliability (internal consistency, test-retest,
etc) and validity (content, construct, criterion-related);
Results of cognitive testing;
Results of field-testing;
Current use of the instrument (who is using it, what it is
being used for, how instrument findings are reported, and by whom the
findings are used); and
Relevant peer-reviewed journal articles or full citations.
When submitting domains, please include, to the extent available:
Detailed descriptions of question domain and specific
purpose;
Sample questions, in all languages available; and
Relevant peer-reviewed journal articles or full citations.
For all submissions, please also include:
A brief cover letter summarizing the information requested
above for submitted instruments and domains, respectively;
Complete information about the person submitting the
material, including:
(a) Name;
(b) Title;
(c) Organization;
(d) Mailing address;
(e) Telephone number;
(f) Email address; and
(g) The written statement granting AHRQ the necessary rights to
use, modify, and adapt the submitted instruments, items, and their
supporting documentation for the development of the survey and its
dissemination for AHRQ purposes, as described above.
FOR FURTHER INFORMATION CONTACT: Maushami DeSoto, MHA, Ph.D.
SUPPPLEMENTARY INFORMATION: Section 401(a) of the Children's Health
Insurance Program Reauthorization Act of 2009 (CHIPRA), Public Law 111-
3, amended the Social Security Act (the Act) to enact section 1139A (42
U.S.C. 1320b-9a). Since the law was passed, the Agency for Healthcare
Research and Quality (AHRQ) and the Centers for Medicare & Medicaid
Services (CMS) have been working together to implement selected
provisions of the legislation related to children's health care
quality. Section 1139A(b) of the Act charged the Department of Health
and Human Services with improving pediatric health care quality
measures. To implement the law, AHRQ and CMS have established the
CHIPRA Pediatric Quality Measures Program (PQMP), which is designed to
enhance select pediatric quality measures and develop new measures as
needed.
The Children's Hospital Boston Center of Excellence for Pediatric
Quality Measurement (CEPQM) is one of seven CHIPRA PQMP Centers of
Excellence, which were created pursuant to an interagency agreement
between CMS and AHRQ and funded through cooperative agreement awards
with AHRQ. CEPQM has been assigned to develop a family experience of
pediatric inpatient care measure to be considered as a standardized
instrument for publicly reporting pediatric inpatient hospital family
experiences voluntarily by State Medicaid and CHIP programs and to be
used by providers, consumers, other public and private purchasers, and
others. The team developing this survey intends to submit it to the
CAHPS Consortium to request use of the CAHPS trademark.
Existing instruments or domains submitted should capture the
family's experience of hospital or related care (for example,
preparation for discharge or care coordination). The survey development
team is looking for items
[[Page 81947]]
for which families of pediatric inpatients are generally the best or
only judge; for example, the family can best say if the provider spent
sufficient time with them or explained things in ways they could
understand. Existing instruments that have been tested should have a
high degree of reliability and validity; and evidence of wide use will
be helpful.
Dated: December 20, 2011.
Carolyn M. Clancy,
AHRQ Director.
[FR Doc. 2011-33290 Filed 12-28-11; 8:45 am]
BILLING CODE 4160-90-M
